Bibi Fell invited Dr. Jim Geller out for a drink in San Diego one chilly evening. A year earlier, his pediatric liver team ...

Mycoplasma pneumoniae (M. pneumoniae)-associated community-acquired pneumonia (CAP) incidence was significantly higher in ...

Ihuoma Eneli, MD, MS, discusses early intervention in childhood obesity to reduce long‑term risk and supporting families with ...

About 5% of people with multiple sclerosis (MS) are diagnosed before age 18. Because pediatric MS is uncommon, little is known about the experiences of children and adolescents living with MS.

Other studies have examined tolerance of pediatric MS patients to treatment with interferonbeta (Adams, Tyor, & Holden, 1999; Krupp et al., 2005; Mikaeloff et al., 2001; Waubant et al., 2001 ...

Recent highlights in MS coverage focus on biomarkers, pregnancy, and neurodegeneration. Physician’s Weekly has compiled a ...

This research highlights emerging injury patterns in youth ice hockey, specifically a rise in serious head and shoulder injuries after the pandemic. Understanding these trends can inform safer ...

Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.

Researcher Kathleen A. Noorbakhsh, MD, MS, is a pediatric emergency-medicine expert at UVA Health and the University of ...

TUESDAY, June 17, 2025 (HealthDay News) -- Individuals with pediatric-onset multiple sclerosis (POMS) have greater epigenetic age and age acceleration residual (AAR) compared with age-similar ...